Response by Saito et al to Letter Regarding Article, “Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial”

Letter by Ahmed et al Regarding Article, “Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial”

Circulation ◽

10.1161/circulationaha.116.026646 ◽

2017 ◽

Vol 135 (18) ◽

Cited By ~ 1

Author(s):

Sofia B. Ahmed ◽

Amy Metcalfe ◽

Kara Nerenberg

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Events ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Dose Aspirin ◽

Faculty Opinions recommendation of Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727018831.793529144 ◽

2017 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Events ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Dose Aspirin ◽

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients with Type 2 Diabetes: A Randomized Controlled Trial

Journal of Vascular Surgery ◽

10.1016/j.jvs.2009.03.020 ◽

2009 ◽

Vol 49 (5) ◽

pp. 1357-1358

Author(s):

H. Ogawa ◽

M. Nakayama ◽

T. Morimoto

Keyword(s):

Type 2 Diabetes ◽

Primary Prevention ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Dose Aspirin ◽

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial

JAMA ◽

10.1001/jama.2008.623 ◽

2008 ◽

Vol 300 (18) ◽

pp. 2134 ◽

Cited By ~ 534

Author(s):

Hisao Ogawa

Keyword(s):

Type 2 Diabetes ◽

Primary Prevention ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Dose Aspirin ◽

Incorrect Data in Text and Table in: Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial

JAMA ◽

10.1001/jama.301.18.1882 ◽

2009 ◽

Vol 301 (18) ◽

pp. 1882 ◽

Cited By ~ 1

Keyword(s):

Type 2 Diabetes ◽

Primary Prevention ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Dose Aspirin ◽

Low Dose Aspirin ◽

Incorrect Data

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus

Circulation ◽

10.1161/circulationaha.116.025760 ◽

2017 ◽

Vol 135 (7) ◽

pp. 659-670 ◽

Cited By ~ 71

Author(s):

Yoshihiko Saito ◽

Sadanori Okada ◽

Hisao Ogawa ◽

Hirofumi Soejima ◽

Mio Sakuma ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Primary Prevention ◽

Cardiovascular Events ◽

Low Dose ◽

Dose Aspirin ◽

Faculty Opinions recommendation of Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1144941.602044 ◽

2009 ◽

Author(s):

Timothy Lyons ◽

Madona Azar

Keyword(s):

Type 2 Diabetes ◽

Primary Prevention ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Dose Aspirin ◽

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Yearbook of Vascular Surgery ◽

10.1016/s0749-4041(09)79136-5 ◽

2009 ◽

Vol 2009 ◽

pp. 6-7

Author(s):

G.L. Moneta

Keyword(s):

Type 2 Diabetes ◽

Primary Prevention ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Dose Aspirin ◽

Data Error in Table in: Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial

JAMA ◽

10.1001/jama.2012.14657 ◽

2012 ◽

Vol 308 (18) ◽

pp. 1861

Keyword(s):

Type 2 Diabetes ◽

Primary Prevention ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Dose Aspirin ◽

Low Dose Aspirin ◽

Data Error

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomized controlled trial

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)70036-2 ◽

2007 ◽

Vol 2007 ◽

pp. 63-65

Author(s):

J.L. Leahy

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Field Study ◽

Cardiovascular Events ◽

Controlled Trial ◽

Randomized Controlled